<DOC>
	<DOCNO>NCT00879775</DOCNO>
	<brief_summary>Pain common symptom high impact quality life cancer patient . Many cancer patient receive opioid therapy , also many suffer side effect opioids . Drowsiness confusion common side effect opioids . Caffeine well know psychostimulant , widely use analgesic . Thus , investigator aim prove efficacy intravenous caffeine administration adjuvant analgesic opioids . At time , investigator try find side effect opioids could ameliorate caffeine .</brief_summary>
	<brief_title>Efficacy Caffeine Injection Adjuvant Opioid Therapy Cancer Pain</brief_title>
	<detailed_description>Previous study cancer pain lack assessment quality life . And previous study cancer pain give attention symptom accompany pain . We include variable outcome measure , aim evaluate efficacy safety intravenous caffeine advance cancer inpatient .</detailed_description>
	<mesh_term>Caffeine</mesh_term>
	<mesh_term>Caffeine , sodium benzoate drug combination</mesh_term>
	<mesh_term>Sodium Benzoate</mesh_term>
	<criteria>Advanced ( Stage IV ) cancer inpatient Adults age 18 year Patients receive opioid therapy whose pain scale 6 ( numeric rating scale ) Patients take caffeine beverage 48 hour study period Volunteers provide write informed consent Sensitivity ( palpitation , headache , irritability , insomnia ) caffeine Uncontrolled hypertension and/or heart disease Liver failure ( alanine aminotransferase &gt; = 100 IU/L ) Kidney failure ( serum creatinine &gt; = 2.0 mg/dL ) Patients take theophylline Gastroesophageal reflux disease Chronic glaucoma Cognitive impairment Progressive pain 7 ( numeric rating scale )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Pain</keyword>
	<keyword>Cancer patient</keyword>
	<keyword>Caffeine</keyword>
	<keyword>Adjuvant analgesic</keyword>
	<keyword>Sedation</keyword>
	<keyword>Confusion</keyword>
	<keyword>Quality life</keyword>
	<keyword>Fatigue</keyword>
</DOC>